HealthDay - TUESDAY, June 1 (HealthDay News) -- A widely prescribed type of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) appear to boost the risk for developing cataracts among seniors, according to the first study to explore the subject.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.